[Usefulness of combined positron emission tomography and computed tomography imaging in Erdheim-Chester disease]

Rev Med Interne. 2007 Nov;28(11):770-4. doi: 10.1016/j.revmed.2007.05.036. Epub 2007 Jun 27.
[Article in French]

Abstract

Introduction: Erdheim-Chester disease is a rare non-Langerhans form of histiocytosis. We report the use of combined fluorodeoxyglucose positron emission tomography and computed tomography (18F-FDG PET-CT) in this disease.

Exegesis: Three men, aged from 55 to 74 years with confirmed Erdheim-Chester disease were included. 18F-FDG PET-CT allowed to detect visceral and vascular involvement of the disease which were overlooked with CT-scan or magnetic resonance imaging: left common carotid and ilio-femoral artery in one patient, coronary, femoral and tibia in the second, aortic, common carotid, femoral and mandibula in the remaining patient. Also, sequential 18F-FDG PET-CT was useful to appreciate treatment efficiency (decrease hyperfixation) and decide treatment modification (interferon alpha).

Conclusion: 18F-FDG PET-CT combined imaging allows to assess the extent of involvement in Erdheim-Chester disease. 18F-FDG PET-CT may be also a useful tool in the management of Erdheim-Chester disease.

MeSH terms

  • Aged
  • Aorta, Thoracic / diagnostic imaging
  • Erdheim-Chester Disease / diagnostic imaging*
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Tomography, X-Ray Computed

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18